Putting some of its recent IPO money to use, Precision Biosciences has opened a manufacturing center to prepare it for commercial manufacturing and clinical development. The Durham-based pharmaceutical company (Nasdaq: DTIL) has leased a 17,300 square-foot facility in the BioPoint Innovation Labs in Research Triangle Park. Exact financial details were not disclosed, but company officials say it is part of a $26 million investment on facility expansions in North Carolina.